CYP 266
Pill imprint CYP 266 has been identified as Guaifenesin and pseudoephedrine hydrochloride SR 1200 mg / 120 mg.
Guaifenesin/pseudoephedrine is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy.
Guaifenesin/pseudoephedrine 1200 mg / 120 mg is not subject to the Controlled Substances Act.
See also related documents.
Guaifenesin and pseudoephedrine hydrochloride SR Images
- Imprint:
-
CYP 266
- Strength:
- 1200 mg / 120 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Cypress Pharmaceutical Inc
- National Drug Code (NDC):
- 60258-0266
More Guaifenesin and Pseudoephedrine Hydrochloride SR resources
- Guaifenesin and Pseudoephedrine Hydrochloride SR Side Effects
- Guaifenesin and Pseudoephedrine Hydrochloride SR Use in Pregnancy & Breastfeeding
- Guaifenesin and Pseudoephedrine Hydrochloride SR Drug Interactions
- Support Group Q & A
- 57 Reviews for Guaifenesin and Pseudoephedrine Hydrochloride SR - Add your own review/rating
- Guaifenesin/Pseudoephedrine (Wolters Kluwer)
- Guaifenesin/Pseudoephedrine Capsules (Wolters Kluwer)
- Guaifenesin/Pseudoephedrine Controlled-Release Capsules (Wolters Kluwer)
- Guaifenesin/Pseudoephedrine Liquid (Wolters Kluwer)
- Guaifenesin/Pseudoephedrine Sustained-Release Tablets (Wolters Kluwer)
- Triaminic Chest/Nasal Liquid (Wolters Kluwer)
- Triaminic Softchews Chest Congestion (Cerner Multum)
- guaifenesin and pseudoephedrine (Cerner Multum)
- Mucinex D Maximum Strength (FDA)


